AudiologyOnline Phone: 800-753-2160


Cochlear Osia System - October 2023

Cochlear Launches New Habilitation Program for Hearing-Impaired Children

Share:

DENVER - June 2003 - Cochlear, the market leader in cochlear implant technology, recently announced the availability of Listen, Learn and Talk, a new auditory habilitation program for infants and children under four years of age. Cochlear's Listen, Learn and Talk habilitation package is a practical "how to" auditory learning program designed for babies and infants diagnosed with a hearing loss from birth to school age. It is a valuable resource for parents and professionals based on the principles of early listening and spoken language development.

"Cochlear prides itself on its commitment to helping Cochlear Nucleus® recipients achieve successful outcomes with their implants," said Jim Miller, president, Cochlear Americas. "Habilitation is a critical factor in achieving success with the implant and developing speech and language skills. The Listen, Learn and Talk program provides our recipients with the tools needed to attain this goal."

About Listen, Learn and Talk
The Listen, Learn and Talk package is comprised of a book entitled Listen, Learn and Talk and three videos, Babies Babble, Toddlers Talk and Children Chatter. The Listen, Learn and Talk book outlines the theory and strategies used in hearing development and addresses age-specific habilitation approaches. The videos explore age specific segments ranging from birth to four and contain footage from actual habilitation sessions. The videos also illustrate how the different habilitation methods can be integrated into everyday routines.

For more information on Listen, Learn and Talk, contact Cochlear at 800/458-4999 (Voice) or 800/483-3123 (TTY) or visit the website at www.cochlear.com.

About Cochlear Americas
Denver-based Cochlear Americas is the U.S. headquarters for Cochlear Limited, the world leader in cochlear implant technology. Cochlear is a winner of the 2001 Medical Design Excellence Awards for its design of the Cochlear Nucleus® 24 Contour implant and the FDA Commissioner's Special Citation for the development and commercialization of the Cochlear Nucleus® 24 Multichannel Auditory Brainstem implant. To date, more than 45,000 people worldwide have received Cochlear Nucleus® implants. For more information about Cochlear's products, call the Cochlear Nucleus Hotline at 800/458-4999 (Voice) or 800/483-3123 (TTY) or visit the website at www.cochlear.com.

For more information on Cochlear Americas click here.

Best of AudiologyOnline Top-rated courses | Earn 10 hours on demand! sponsored by CaptionCall

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.